PURPOSE OF REVIEW: Vaccines for human papillomavirus and herpes simplex virus are currently in development, and these vaccines could be an effective and cost-effective strategy to control these diseases. Young adolescents are likely to be the target recipients of these vaccines. These vaccines, however, will only be successful in reducing the prevalence of these diseases if accepted. This manuscript will focus on the issues associated with the acceptability of these vaccines by healthcare providers, parents, and adolescents/young adults. RECENT FINDINGS: Recent studies with healthcare providers, parents, and adolescent/young adults have found support for the acceptability of the human papillomavirus and herpes simplex virus vaccines. Protecting adolescents from serious diseases may be a more important priority for parents than concern about how the disease is transmitted. SUMMARY: It is likely that vaccines for human papillomavirus and herpes simplex virus will find acceptance among these groups. Strategies to increase acceptability and foster access, however, will still be needed.
PURPOSE OF REVIEW: Vaccines for human papillomavirus and herpes simplex virus are currently in development, and these vaccines could be an effective and cost-effective strategy to control these diseases. Young adolescents are likely to be the target recipients of these vaccines. These vaccines, however, will only be successful in reducing the prevalence of these diseases if accepted. This manuscript will focus on the issues associated with the acceptability of these vaccines by healthcare providers, parents, and adolescents/young adults. RECENT FINDINGS: Recent studies with healthcare providers, parents, and adolescent/young adults have found support for the acceptability of the human papillomavirus and herpes simplex virus vaccines. Protecting adolescents from serious diseases may be a more important priority for parents than concern about how the disease is transmitted. SUMMARY: It is likely that vaccines for human papillomavirus and herpes simplex virus will find acceptance among these groups. Strategies to increase acceptability and foster access, however, will still be needed.
Authors: Nadja A Vielot; Shoshana K Goldberg; Gregory Zimet; Sara B Smith; Mary Anne McDonald; Silvina Ramos; Karen Morgan; Chan Joo Kim; Karin L Richter; Merce Peris; Kevin J Whaley; Jennifer S Smith Journal: Papillomavirus Res Date: 2017-04-06